3

FORM 3 SUBMISSION

Company: NovaBay Pharmaceuticals, Inc.
Filed: December 2, 2013
Period of Report: May 31, 2013
Accession Number: 0001209191-13-054686

View Document ↗ View on SEC.gov ↗